SCHEMBL9370596

SCHEMBL9370596

CCOC(n1cnc(-c2ccccc2)c1-c1ccccc1)[Si](C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
NSD3 Q9BZ95 1/20 0.41
PTGS2 P35354 5/20 0.40
TSHR P16473 1/20 0.39
FAAH O00519 4/20 0.38
MAPK13 O15264 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
FRK P42685 1/20 0.36
MAPK9 P45984 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CSNK1D P48730 1/20 0.36
GSK3B P49841 1/20 0.36
PRKD2 Q9BZL6 1/20 0.36
MAP4K5 Q9Y4K4 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6662264 0.75 MEN1 (0.49) LMNATSHRHDAC8MEN1KMT2A
SCHEMBL10887823 0.75 LMNA (0.41) LMNANSD3PTGS2TSHRFAAH
SCHEMBL20466312 0.74 MAPK14 (0.60) LMNANSD3PTGS2TSHRFAAH
SCHEMBL9370600 0.72 PTGS2 (0.50) LMNANSD3PTGS2TSHRFAAH
SCHEMBL10711047 0.71 LMNA (0.50) LMNANSD3PTGS2TSHRFAAH
SCHEMBL6593879 0.70 LMNA (0.53) LMNANSD3PTGS2TSHRFAAH
SCHEMBL6595234 0.70 LMNA (0.46) LMNANSD3PTGS2TSHRFAAH
SCHEMBL11175120 0.69 MAPK14 (0.59) MAPK13MAPK12MAPK11MAPK14
SCHEMBL6593349 0.69 LMNA (0.43) LMNANSD3PTGS2TSHRFAAH
SCHEMBL6844312 0.69 LMNA (0.51) LMNANSD3PTGS2TSHRFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5318984-A Anticholesterol agents which inhibit acetyl coenzyme A transferase THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-06-07 US disclosed
EP-0597003-A1 QUINOLINE DERIVATIVES AS IMMUNOSTIMULANTS PFIZER INC. (US) 1994-05-18 EP disclosed
EP-0372445-B1 Imidazoles for the treatment of atherosclerosis DU PONT MERCK PHARMA (US) 1994-03-09 EP disclosed
WO-1993003030-A1 QUINOLINE DERIVATIVES AS IMMUNOSTIMULANTS PFIZER INC. (US) 1993-02-18 WO disclosed
US-5166214-A Enzyme inhibitors for anticholesterol agents, enzyme inhibitor and cardiovascular disorders DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-11-24 US disclosed
WO-1991018885-A1 IMIDAZOLES FOR THE TREATMENT OF ATHEROSCLEROSIS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1991-12-12 WO disclosed
EP-0372445-A1 Imidazoles for the treatment of atherosclerosis THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1990-06-13 EP disclosed